333-116-0050 Notifications (1) A licensee shall provide the Authority, no later than 30 days after the date that the licensee permits an individual to work under the provisions of OAR 333-116-0040 as an authorized user, authorized medical physicist, ophthalmic physicist, or authorized nuclear pharmacist: (a) A copy of the board certification and, as appropriate, verification of completion of: (A) Training for the authorized medical physicist under OAR 333-116-0905; (B) Any additional case experience required in OAR 333-116-0680 for an authorized user under OAR 333-116-0360; or (C) Device specific training in OAR 333-116-0720 for the authorized user under OAR 333-116-0480; or (b) A copy of the U.S. Nuclear Regulatory Commission or Agreement State license, the permit issued by a Commission master material licensee, the permit issued by a Commission or Agreement State licensee of broad scope, the permit issued by a U.S. Nuclear Regulatory Commission master material license broad scope permittee, or documentation that only accelerator-produced radioactive materials, discrete sources of radium-226, or both, were used for medical use or in the practice of nuclear pharmacy at a government agency or federally recognized Indian Tribe before November 30, 2007, or at all other locations of use before August 8, 2009, or an earlier date as noticed by the NRC for each individual whom the licensee permits to work under the provisions of this section. (2) A licensee shall notify the Authority no later than 30 days after: (a) An authorized user, an authorized nuclear pharmacist, a Radiation Safety Officer, Associate Radiation Safety Officer, authorized medical physicist, or ophthalmic physicist permanently discontinues performance of duties under the license or has a name change; (b) The licensee permits an individual qualified to be a Radiation Safety Officer under OAR 333-116-0640 and OAR 333-116-0760 to function as a temporary Radiation Safety Officer and to perform the functions of a Radiation Safety Officer in accordance with OAR 333-116-0090; (c) The licensee's mailing address changes; (d) The licensee's name changes, but the name change does not constitute a transfer of control of the license as described in OAR 333-102-0305; (e) The licensee has added to or changed the areas of use identified in the application or on the license where byproduct material is used in accordance with either OAR 333-116-0300 or 333-116-0320 if the change does not include addition or relocation of either an area where PET radionuclides are produced or a PET radioactive drug delivery line from the PET radionuclide/PET radioactive drug production area; or (f) The licensee obtains a sealed source for use in manual brachytherapy from a different manufacturer or with a different model number than authorized by its license for which it did not require a license amendment as provided in OAR 333-116-0040. The notification must include the manufacturer and model number of the sealed source, the isotope, and the quantity per sealed source. (3) The licensee shall send the documents required in this section to the Authority at Radiation Protection Services, 800 N.E. Oregon St., Suite 640, Portland Oregon, 97232. Statutory/Other Authority: ORS 453.635 Statutes/Other Implemented: ORS 453.605 - 453.807 History: PH 174-2022, minor correction filed 08/11/2022, effective 08/11/2022 PH 81-2021, amend filed 11/19/2021, effective 11/23/2021 PH 4-2013, f. & cert. ef. 1-29-13 PH 14-2008, f. & cert. ef. 9-15-08 PH 4-2007, f. & cert. ef. 3-1-07 PH 12-2006, f. & cert. ef. 6-16-06 PH 36-2004, f. & cert. ef. 12-1-04 PH 31-2004(Temp), f. & cert. ef. 10-8-04 thru 4-5-05 PH 3-2003, f. & cert. ef. 3-27-03 HD 1-1991, f. & cert. ef. 1-8-91